The Daily Mail, Pakistan
Sinovac's vaccine trail shows potential virus defense
  ·  2020-07-09  ·   Source: Daily Mail
Sinovac Biotech Ltd., a Beijing-based biopharmaceutical company that focuses on research and development of vaccines that protect against infectious diseases, said in a press release on June 14 that its novel coronavirus disease (COVID-19) shot is safe and capable of eliciting an immune response in humans, suggesting the shot's potential in defending against infection of COVID-19. 

Its vaccine called CoronaVac hasn't caused severe side effects and more than 90 percent of people administered with the shot on a 14-day interval have induced neutralizing antibodies two weeks after inoculation, the company said. 

The preliminary findings come from phase I and II trials in China. A total of 743 healthy people ages 18 to 59 either received shots on two schedules or a placebo. More data will be uncovered from another group in the trial that received shots on a 28-day interval. Sinovac plans to publish its results in academic journals, according to a spokesman of the company. 

Using a killed version of the COVID-19, Sinovac's vaccine is among five Chinese experimental shots that have reached the crucial final stage of human testing before they can be approved for public use. The company announced a partnership in June this year with Instituto Butantan to conduct its phase III trial in Brazil, where the novel pathogen has caused the second-largest outbreak in a global pandemic that so far infected more than 7.7 million people and killed over 428,000. 

China
Opinion
World
Business
Lifestyle
Video
Multimedia
 
China Focus
Documents
Special Reports
 
About Us
Contact Us
Advertise with Us
Subscribe
Partners: China.org.cn   |   China Today   |   China Pictorial   |   People's Daily Online   |   Women of China   |   Xinhua News Agency   |   China Daily
CGTN   |   China Tibet Online   |   China Radio International   |   Global Times   |   Qiushi Journal
Copyright Beijing Review All rights reserved 京ICP备08005356号 京公网安备110102005860